In-vitro efficacy of antibiotics released from calcium sulfate bone void filler beads

Abstract

Fifteen different antibiotics were individually mixed with a commercially available calcium sulfate bone void filler beads. The antibiotics were: amikacin, ceftriaxone, cefuroxime, ciprofloxacin, clindamycin, colistamethate sodium, daptomycin, gentamicin, imipenem/cilastatin, meropenem, nafcillin, rifampicin, teicoplanin, tobramycin and vancomycin. The efficacy of specific released antibiotics were validated by zone of inhibition (ZOI) testing using a modified Kirby—Bauer disk diffusion method against common periprosthetic joint infection pathogens. With a subset of experiments (daptomycin, rifampin, vancomycin alone and rifampin and vancomycin in combination) we investigated how release varied over 15 days using a repeated ZOI assay. We also tested the ability of these beads to kill biofilms formed by Staphylococcus epidermidis 35984, a prolific biofilm former. The results suggest that certain antibiotics can be combined and released from calcium sulfate with retained antibacterial efficacy. The daptomycin and rifampin plus vancomycin beads showed antimicrobial efficacy for the full 15 days of testing and vancomycin in combination with rifampin prevented resistant mutants. In the biofilm killing assay all of the antibiotic combinations showed a significant reduction in biofilm bacteria after 24 hr. The exposure time was an important factor in the amount of killing and varied among the antibiotics.

More information

Identifiers

ORCID for Paul Stoodley: orcid.org/0000-0001-6069-273X

Catalogue record

Export record

Altmetrics